ArticleOncology letters2017

Interleukin-6 identified as an important factor in hypoxia- and aldehyde dehydrogenase-based gefitinib adaptive resistance in non-small cell lung cancer cells.

Shi-Min An et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.